Abstract
A SERS colloidal solution of gold nanoparticles is proposed as a sensing platform potentially suitable for the Therapeutic Drug Monitoring of the anticancer drug 6-mercaptopurine. The as-synthesized nanospheres were fully characterized in terms of morphological features, plasmonic properties and SERS activity. Modifying the pH of the colloidal solution toward acidic values allowed us to improve considerably the platform sensitivity. A kinetic analysis performed at different analyte concentrations revealed the occurrence of adsorption/aggregation processes which induced a time-dependent SERS response. This dependence, causing unreliable quantitative analysis, was accounted for by a normalizing procedure based on the enhanced elastic scattering signal. After normalization for hot-spot concentration, a 1 – 15 μM linearity range was identified, within which the quantitative analysis is accurate and reproducible. The working range of the present assaying platform is suitable for clinical applications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
